Table I.
Expression of EpCAM/CD44 in colorectal cancer.
| Variable | Samples, n | EpCAMhigh/CD44+ cells, % | P-value |
|---|---|---|---|
| Gender | 1.000 | ||
| Male | 38 | 0.99±1.11 | |
| Female | 42 | 0.99±0.90 | |
| Patient age, years | 0.212 | ||
| >60 | 44 | 0.84±1.04 | |
| ≤60 | 36 | 1.12±0.96 | |
| Tumor magnitude, cm | 0.051 | ||
| ≤5×5 | 50 | 0.80±0.73 | |
| >5×5 | 30 | 1.31±1.29 | |
| Differentiation | <0.001a | ||
| High | 10 | 0.53±0.93 | |
| Moderate | 51 | 0.74±0.68 | |
| Low | 19 | 1.90±1.23 | |
| Tumor stage | 0.002a | ||
| T1+T2 | 18 | 0.49±0.43 | |
| T3 | 28 | 0.80±0.43 | |
| T4 | 34 | 1.41±1.00 | |
| Dukes’ stage | <0.001a | ||
| A | 16 | 0.42±0.39 | |
| B | 16 | 0.62±0.74 | |
| C | 22 | 0.89±0.66 | |
| D | 26 | 1.66±1.26 | |
| Metastasis | <0.001a | ||
| Negative | 32 | 0.52±0.59 | |
| Positive | 48 | 1.31±1.09 |
a
P<0.05.
EpCAM, epithelial cell adhesion molecule; CD, cluster of differentiation.